Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic cancer

R E Brand1, M A Tempero

  • 1Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-2000, USA.

Current Opinion in Oncology
|August 14, 1998
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer is a difficult disease to treat, despite recent advances. Current research focuses on improving diagnosis and treatment through better staging and therapies like gemcitabine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance for pancreatic cancer in high-risk individuals.

BJS open·2019
Same author

An Unexpected Etiology of Pancreatic Panniculitis: A Case Report.

Journal of pancreatic cancer·2017
Same author

Serum and hair selenium levels in hereditary nonpolyposis colorectal cancer.

Biological trace element research·2013
Same author

The effect of selenium on cell proliferation in liver and colon.

Biological trace element research·2013
Same author

In vitro regulation of human lymphocyte proliferation by selenium.

Biological trace element research·2013
Same author

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.

British journal of cancer·2013
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Medical Imaging
  • Gastroenterology

Background:

  • Pancreatic cancer presents significant therapeutic challenges despite ongoing advancements.
  • Helical computed tomography (CT) is widely adopted for staging pancreatic cancer.
  • The optimal use of chemoradiation therapy in perioperative settings is under investigation.

Purpose of the Study:

  • To review recent advances in the diagnosis, staging, and treatment of pancreatic adenocarcinoma.
  • To highlight the current role of helical CT in staging.
  • To discuss the evolving applications of chemoradiation and gemcitabine therapy.

Main Methods:

  • Review of recent literature on pancreatic cancer management.
  • Discussion of imaging techniques, specifically helical CT for staging.

Related Experiment Videos

  • Analysis of current chemoradiation protocols and first-line pharmacotherapy.

    • Main Results:

    • Helical CT is the preferred staging modality in many centers.
    • Gemcitabine is established as the first-line treatment for advanced pancreatic adenocarcinoma.
    • The role of perioperative chemoradiation is actively being defined.

    Conclusions:

    • Despite progress, pancreatic cancer remains a major clinical challenge.
    • Advances in molecular biology are anticipated to enhance future diagnostic and therapeutic strategies.
    • Improved understanding of pancreatic carcinoma biology is key to better patient outcomes.